Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.
about
Strategically targeting MYC in cancerLeveraging big data to transform target selection and drug discoveryNarrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesMapping the Pathways of Resistance to Targeted TherapiesActivity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.Direct and indirect targeting of MYC to treat acute myeloid leukemiaClinical implications of molecular heterogeneity in triple negative breast cancer.A reactivity-based probe of the intracellular labile ferrous iron pool.Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell PathogenicityA Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer ModelsLYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network.Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins.A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance.
P2860
Q26747745-090F2767-B7DC-477E-9AD3-4AEFF98C1098Q26776403-1116C7C8-A916-4D4B-90BF-F55605DCC8E5Q28072745-21950126-1D2C-4951-91EF-20F500770E02Q28088791-A5D19C2D-AD52-423F-A106-8FE02867C5D0Q30299995-1F40D7CC-1F4E-4057-BB0A-0B1902CAAEF4Q35798798-C982BAD7-CF8D-4F7B-9BC0-C3A5CB7CCAA5Q36271396-96194E24-A5D7-4C25-AEE7-623361327E8BQ37187937-7152BA6F-A84F-451A-9DA0-37A022AFCD08Q37195656-37B35921-F81D-46E7-AD87-F887DB31778CQ37532072-7F825E0A-A072-4F96-965C-88BA7CE46E3FQ37696232-1F88ADAD-2013-43F7-B082-B1892C33E43EQ38838357-0AB60CFA-7F4E-498A-A56C-0230296D9184Q42367759-81C06574-3205-44F4-8B6C-AD8B6AFF2EC9Q47143892-0B16F5C9-919B-4098-85D3-2EE2F2022314Q47155275-1D258E38-D02F-4798-9FF0-587EA117FBC6Q48187016-4A9F6E7A-A2D0-4EA8-9EA0-C38CAB883934Q53694059-58624C4C-6EEF-4C1D-9AAE-2AD319C632C4
P2860
Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Linking tumor mutations to dru ...... mical-genetic interaction map.
@ast
Linking tumor mutations to dru ...... mical-genetic interaction map.
@en
type
label
Linking tumor mutations to dru ...... mical-genetic interaction map.
@ast
Linking tumor mutations to dru ...... mical-genetic interaction map.
@en
prefLabel
Linking tumor mutations to dru ...... mical-genetic interaction map.
@ast
Linking tumor mutations to dru ...... mical-genetic interaction map.
@en
P2093
P2860
P1433
P1476
Linking tumor mutations to dru ...... mical-genetic interaction map.
@en
P2093
Alexandra Corella
Alykhan F Shamji
Andrei Goga
Antonio Sorrentino
Christina Yau
Dai Horiuchi
Frank McCormick
Jaime Cheah
Jeff Johnson
John D Gordan
P2860
P304
P356
10.1158/2159-8290.CD-14-0552
P577
2014-12-12T00:00:00Z